Medifast, Inc. (LON:0K05)

Medifast Statistics

Total Valuation

Medifast has a market cap or net worth of GBP 82.16 million. The enterprise value is -34.73 million.

Market Cap	82.16M
Enterprise Value	-34.73M

Important Dates

The last earnings date was Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	10.31M
Shares Outstanding	n/a
Shares Change (YoY)	+0.16%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.00%
Owned by Institutions (%)	71.07%
Float	9.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.29
PB Ratio	0.56
P/TBV Ratio	0.56
P/FCF Ratio	88.53
P/OCF Ratio	16.11
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	2.50
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-37.43

Financial Position

The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.05.

Current Ratio	4.69
Quick Ratio	3.89
Debt / Equity	0.05
Debt / EBITDA	2.17
Debt / FCF	8.56
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -9.13% and return on invested capital (ROIC) is -29.67%.

Return on Equity (ROE)	-9.13%
Return on Assets (ROA)	-3.34%
Return on Invested Capital (ROIC)	-29.67%
Return on Capital Employed (ROCE)	-6.93%
Weighted Average Cost of Capital (WACC)	6.79%
Revenue Per Employee	754,317
Profits Per Employee	-36,509
Employee Count	380
Asset Turnover	1.45
Inventory Turnover	3.53

Taxes

In the past 12 months, Medifast has paid 9.68 million in taxes.

Income Tax	9.68M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.17% in the last 52 weeks. The beta is 0.58, so Medifast's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-28.17%
50-Day Moving Average	11.07
200-Day Moving Average	12.64
Relative Strength Index (RSI)	41.80
Average Volume (20 Days)	2,759

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	8.00

Income Statement

In the last 12 months, Medifast had revenue of GBP 286.64 million and -13.87 million in losses. Loss per share was -1.26.

Revenue	286.64M
Gross Profit	204.46M
Operating Income	-10.56M
Pretax Income	-4.19M
Net Income	-13.87M
EBITDA	21,547
EBIT	-10.56M
Loss Per Share	-1.26

Balance Sheet

The company has 124.28 million in cash and 7.95 million in debt, with a net cash position of 116.34 million.

Cash & Cash Equivalents	124.28M
Total Debt	7.95M
Net Cash	116.34M
Net Cash Per Share	n/a
Equity (Book Value)	147.80M
Book Value Per Share	14.33
Working Capital	117.93M

Cash Flow

In the last 12 months, operating cash flow was 5.10 million and capital expenditures -4.17 million, giving a free cash flow of 928,007.

Operating Cash Flow	5.10M
Capital Expenditures	-4.17M
Free Cash Flow	928,007
FCF Per Share	n/a

Margins

Gross margin is 71.33%, with operating and profit margins of -3.68% and -4.84%.

Gross Margin	71.33%
Operating Margin	-3.68%
Pretax Margin	-1.46%
Profit Margin	-4.84%
EBITDA Margin	0.01%
EBIT Margin	-3.68%
FCF Margin	0.32%

Dividends & Yields

Medifast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.16%
Shareholder Yield	-0.16%
Earnings Yield	-16.89%
FCF Yield	1.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medifast has an Altman Z-Score of 4.75 and a Piotroski F-Score of 3.

Altman Z-Score	4.75
Piotroski F-Score	3